Stressgen Biotechnologies
Enrollment completed for clinical trial of internal genital warts treatment
Published in Surgery Litigation and Law Weekly, January 7th, 2005
The study is a single arm pilot study in 30 patients. The primary endpoint of the trial will be complete response measured by complete clearance of baseline internal warts. The study is on schedule and 12-month data are estimated to be available at the end of 2005.
Stephen E. Goldstone, MD, a Fellow of the American College of Surgeons and clinical assistant professor at The Mount...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
More Articles from Surgery Litigation and Law Weekly
- Alteris Therapeutics, Inc.
Anticancer vaccine doubles time-to-disease progression, increases survival - HepaLife Technologies, Inc.
Biotechnology company names new member to scientific advisory board - Information Technology
Cedara introduces software that tracks patient information - International College of Surgeons
British surgeon assumes world presidency of International College of Surgeons - National Neurological Institute C. Besta
Bovine aortic endothelial cell immunization stalls glioma neovascularization - American Society of Hematology
Two studies presented at conference shed light on anticoagulation therapy - More from this issue of Surgery Litigation and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
